Area
Reporting and discussion about Science & Medicine, with links to the original sources.
Biohub's Alex Rives expects pretraining, elicitation and RLVR to carry over from language models to biology, but says verification must happen in the lab. He is unsure whether biology and language models will share one latent space.
Biohub science head Alex Rives argues that no lab animal can ever be a perfect stand-in for people. He says an AI model trained across many species, as protein models were trained across evolution, could predict human biology far better.
Biohub's head of science Alex Rives argues that cell models are held back by what biology can measure. His examples are whole-zebrafish imaging and a laser phase plate for electron microscopes, so far tested only on isolated proteins.
Biohub's head of science, Alex Rives, says virtual cell models fall short above all because biology can't yet measure what matters. He expects an information-level cell model within about five years.
XPRIZE CEO Anousheh Ansari said a prize to store donor organs for months, tested in pigs with a six-month target, won this year's Visioneering. She and Peter Diamandis also described a funded telescope-data prize and less advanced ideas.
A preprint reports GPT-6 Astra got 49 of 50 unpublished physics calculations right with web access, for about $2 each. On Moonshots, XPRIZE CEO Anousheh Ansari asked who will find new problems if AI solves the defined ones.
On Moonshots, Peter Diamandis showed a speech implant from his portfolio company Paradromics and described Sabi's planned brain-reading cap. Dave Blundin argued that AI agents may reverse what such interfaces are for.
Alexander Wissner-Gross forecast that virtual-cell AI will propose small-molecule cures for the top 5,000 diseases within two to three years. He said regulatory approval would be a harder, policy-dependent question.
OpenAI posted hundreds of AI-produced math manuscripts on October 6 and withdrew three a day later. A mathematicians' group objected; on Moonshots, Alex Wissner-Gross argued math is just the first field AI will bulk-solve.
Leash Bio co-founder Ian Quigley says messy DNA-encoded library screens can yield reproducible AI training data, using dozens of barcodes per molecule and hundreds of screens per library. He says absolute binding strength is still out of reach.
Ian Quigley says co-folding models still place a molecule where a pocket was digitally destroyed, so Leash Bio engineers protein mutants for negative data. In a 20-protein exploratory analysis, its model's attention spread more evenly after retraining on mutants plus about 40% more ordinary data.
In Leash Bio's 2024 Kaggle contest, no team beat chance on an unseen chemical library. Ian Quigley says Leash's later Hermes model roughly matched Boltz on public tests without training on outside data, but published results were mixed.